CellCarta SA
242.7 FTECellCarta reported revenue of €79.9m for the 2025 financial year (annual accounts filed with the NBB on 09 Jun 2026), with 242.7 full-time equivalents.
The score of CellCarta shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +50 % Equity +204 % Total assets +36 % Headcount (avg FTE) +18 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CellCarta's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €79.9m | ||||
| Net result | €7.70m | ||||
| Equity | €25.9m | ||||
| Cash | €7.29m | ||||
| EBITDA | €14.4m | ||||
| Total assets | €60.5m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jun 2026
- Year ended 31 Dec 2024filed on 25 Sep 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
CellCarta's financial analysis
- Solvency42.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CellCarta
CellCarta's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.654.355
- VAT number
- BE0474654355
- Peppol
- Registered · 0208:0474654355 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Apr 2001
- Registered office
- 2610 Antwerp
- Size
- Medium · 242.7 FTE
- Latest accounts
- 2025 · filed on 09 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
CellCarta (SA) has been based in Antwerp since 2001, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports revenue of €79.9m, a net profit of €7.70m and equity of €25.9m. With 242.7 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 42.8%, below the median of its sector (60.4%).
Companies similar to CellCarta
Companies in the same business, of comparable size and area, outside its group.
- Biocartis Research and experimental development on natural sciences and engineering Mechelen · balance sheet €61.8m
- Centrum Voor Medische Analyse Diagnostic imaging services and medical laboratory activities Herentals · balance sheet €44.4m
- A.M.L. Diagnostic imaging services and medical laboratory activities Antwerp · balance sheet €104.9m
- Cerba Healthcare Belgium Diagnostic imaging services and medical laboratory activities Anderlecht · balance sheet €107.6m
- Medisch Labo Bruyland Diagnostic imaging services and medical laboratory activities Kortrijk · balance sheet €22.0m
- Legend Biotech Belgium Research and experimental development on natural sciences and engineering Ghent · balance sheet €142.4m
- Ogeda Research and experimental development on natural sciences and engineering Vilvoorde · balance sheet €53.5m
- Laboratoire hospitalier universitaire de Bruxelles - Universitair Laboratorium Brussel Diagnostic imaging services and medical laboratory activities Brussels · balance sheet €27.2m
Frequently asked questions about CellCarta
What is the revenue of CellCarta?
According to the 2025 annual accounts filed with the NBB, the revenue of CellCarta amounts to 79,878,333 €.
What is the VAT number of CellCarta?
In Belgium, the VAT number is the company number prefixed with BE: BE0474654355 for CellCarta, if the company is VAT-registered. Its company number (CBE) is 0474.654.355.
Where is the registered office of CellCarta?
According to the CBE register, the registered office of CellCarta is in 2610 Antwerp.
What is the equity of CellCarta?
At the close of the 2025 financial year, the equity of CellCarta amounts to 25,865,408 €, a solvency of 42.8% of total assets.
How many people work at CellCarta?
242.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages CellCarta?
The register lists 9 active mandates at CellCarta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CellCarta
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →